Literature DB >> 25626342

OPTN/SRTR 2013 Annual Data Report: lung.

M Valapour1, M A Skeans, B M Heubner, J M Smith, M I Hertz, L B Edwards, W S Cherikh, E R Callahan, J J Snyder, A K Israni, B L Kasiske.   

Abstract

Lungs are allocated to adult and adolescent transplant candidates (aged ⩾ 12 years) on the basis of age, geography, blood type compatibility, and the lung allocation score (LAS), which reflects risk of waitlist mortality and probability of posttransplant survival. In 2013, the most adult candidates, 2394, of any year were added to the list. Overall median waiting time for candidates listed in 2013 was 4.0 months. The preferred procedure remained bilateral lung transplant, representing approximately 70% of lung transplants in 2013. Measures of short-term and longterm survival have plateaued since the implementation of the LAS in 2005. The number of new child candidates (aged 0-11 years) added to the lung transplant waiting list increased to 39 in 2013. A total of 28 lung transplants were performed in child recipients, 3 for ages younger than 1 year, 9 for ages 1 to 5 years, and 16 for ages 6 to 11 years. The diagnosis of pulmonary hypertension was associated with higher survival rates than cystic fibrosis or other diagnosis (pulmonary fibrosis, bronchiolitis obliterans, bronchopulmonary dysplasia). For child candidates, infection was the leading cause of death in year 1 posttransplant and graft failure in years 2 to 5. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  End-stage lung disease; lung allocation score; lung transplant; organ allocation; transplant outcomes

Mesh:

Year:  2015        PMID: 25626342     DOI: 10.1111/ajt.13200

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  35 in total

1.  Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival.

Authors:  Chad A Newton; Julia Kozlitina; Jefferson R Lines; Vaidehi Kaza; Fernando Torres; Christine Kim Garcia
Journal:  J Heart Lung Transplant       Date:  2017-02-04       Impact factor: 10.247

2.  Early in vivo experience with the pediatric continuous-flow total artificial heart.

Authors:  Jamshid H Karimov; David J Horvath; Nicole Byram; Gengo Sunagawa; Barry D Kuban; Shengqiang Gao; Raymond Dessoffy; Kiyotaka Fukamachi
Journal:  J Heart Lung Transplant       Date:  2018-03-30       Impact factor: 10.247

3.  Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell-Mediated Antibody-dependent Chronic Rejection.

Authors:  C M Lin; R J Plenter; M Coulombe; R G Gill
Journal:  Am J Transplant       Date:  2016-07-07       Impact factor: 8.086

4.  Lung Transplant Center Volume Ameliorates Adverse Influence of Prolonged Ischemic Time on Mortality.

Authors:  D Hayes; M G Hartwig; J D Tobias; D Tumin
Journal:  Am J Transplant       Date:  2016-07-13       Impact factor: 8.086

5.  Whole-Exome Sequencing Insights into Adult Pulmonary Fibrosis. Repeating the Telomere Theme.

Authors:  Christine Kim Garcia
Journal:  Am J Respir Crit Care Med       Date:  2017-07-01       Impact factor: 21.405

6.  Influence of specific thoracic donor therapy on kidney donation and long-term kidney graft survival.

Authors:  María A Ballesteros; Jorge Duerto Álvarez; Luis Martín-Penagos; Emilio Rodrigo; Manuel Arias; Eduardo Miñambres
Journal:  J Nephrol       Date:  2016-11-09       Impact factor: 3.902

Review 7.  The Future of Lung Transplantation.

Authors:  Katherine A Young; Daniel F Dilling
Journal:  Chest       Date:  2018-08-29       Impact factor: 9.410

8.  Effect of Transplant Center Volume on Cost and Readmissions in Medicare Lung Transplant Recipients.

Authors:  Joshua J Mooney; David Weill; Jack H Boyd; Mark R Nicolls; Jay Bhattacharya; Gundeep S Dhillon
Journal:  Ann Am Thorac Soc       Date:  2016-07

9.  Gender differences in long-term survival post-transplant: A single-institution analysis in the lung allocation score era.

Authors:  Gabriel Loor; Roland Brown; Rosemary F Kelly; Kyle D Rudser; Sara J Shumway; Irena Cich; Christopher T Holley; Colleen Quinlan; Marshall I Hertz
Journal:  Clin Transplant       Date:  2017-02-08       Impact factor: 2.863

10.  Reconstituting Mouse Lungs with Conditionally Reprogrammed Human Bronchial Epithelial Cells.

Authors:  Ryan LaRanger; Jennifer R Peters-Hall; Melissa Coquelin; Busola R Alabi; Christopher T Chen; Woodring E Wright; Jerry W Shay
Journal:  Tissue Eng Part A       Date:  2017-09-25       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.